Brain-based vision loss ranks as the leading cause of visual impairment among children in the US and other developed countries, yet the most widely used tool for gauging how children with the condition use their sight in daily life had long lacked rigorous clinical validation. New evidence has begun to close that gap, with investigators reporting that a standardized functional vision assessment was a valid and reliable measure of how children with cerebral/cortical visual impairment (CVI) use their vision, according to findings published in Ophthalmology Science.
Cerebral/cortical visual impairment is a brain-based disorder that affects the visual processing pathways rather than the eyes themselves. Because standard eye examinations measure visual function such as acuity and contrast sensitivity, they frequently underestimate or miss the everyday visual difficulties children with CVI experience. Clinicians have described a disconnect in which a child’s ability to use vision during daily activities is worse than eye clinic findings would predict. This mismatch is tied to higher-order visual processing deficits that can substantially affect quality of life.
Related: User Blocked After Policy Violation
The CVI Range for Clinical Research (CVI Range-CR) is a standardized version of the CVI Range, an assessment developed decades ago that became the most widely used functional vision measure for children with CVI. The original tool has guided individualized interventions delivered by teachers of students with visual impairments, occupational therapists, and other low vision specialists, but it was often administered in a nonstandardized manner to support personalized recommendations. That flexibility made it poorly suited to serve as an outcome measure in clinical trials, prompting the authors to build a standardized version for research.
The prospective, longitudinal cohort study enrolled 40 children with CVI who were assessed at baseline and again one year later. Participants had a mean age of 4.3 years, and 65 percent were boys. The cohort was racially and ethnically diverse, including children who were White (40 percent), Hispanic or Latino (30 percent), Asian or Pacific Islander (13 percent), and Black or African American (5 percent). All participants had developmental delay, 90 percent had seizures, and 53 percent had cerebral palsy, with common ophthalmic comorbidities including strabismus (78 percent), optic atrophy (43 percent), significant refractive error (43 percent), and nystagmus (30 percent). One-year follow-up assessments were completed for 34 children (85 percent).
High internal consistency was found, with a McDonald’s ω of 0.96. Intraclass correlation coefficients (ICC) ranged from 0.88 to 0.98 when the same grader scored recordings at two time points, indicating excellent intrarater reliability. Interrater reliability among one in-person and two remote graders was good to excellent, with ICCs of 0.74 to 0.88. Scores also correlated strongly with a pediatric neuro-ophthalmologist’s clinical assessment of visual behavior, measured on a six-level visual behavior scale (Spearman correlation coefficient of 0.76 to 0.86; P < .0001), supporting the assessment's validity.
Related: Exploring Non-Invasive Treatments for Erectile Dysfunction
Over one year, scores improved modestly but significantly on both scoring methods (Across-CVI Characteristics average, +0.35 [P = .002]; Within-CVI Characteristics average, +0.31 [P = .001]), and visual behavior scale scores rose in tandem. Because the average difference between graders exceeded the average change over one year, the authors recommended that longitudinal studies use consistent graders, potentially through remote grading of recorded assessments at a centralized reading center.
While the assessment showed strong performance, the findings should be interpreted with several limitations in mind. The cohort skewed toward children with lower levels of functional vision, and only six participants (15 percent) reached the most advanced phase during the study, reflecting the more severe disease typical of a tertiary referral clinic. Enrollment was also limited to children aged 12 months to 10 years, so the results may not apply to older children. Although six participants (15 percent) were lost to follow-up, they did not differ significantly from those retained on baseline demographics or scores.
Related: The Importance Of Regular Dental Check Ups: A General Dentist’s Perspective
For families and clinicians, the shift toward a validated standardized measure is significant. Functional vision assessments are usually subjective, relying heavily on a therapist’s observation of a child in a quiet room. This new tool offers a way to quantify that vision in a way that tracks over time. When a treatment is introduced—whether it is a new therapeutic approach or assistive technology—the ability to prove that it works means the child gets better support sooner. This creates a feedback loop where interventions can be adjusted based on data rather than guesswork.
The authors acknowledged that the time required to train examiners, administer the assessment, and score it remains a barrier to wider use in multicenter research. They said planned work would use artificial intelligence to develop a shorter version with automated scoring so future CVI trials could judge treatments not only by what clinicians measure in the eye clinic but also by how children use their vision at home and school.
